|Seed, 9/2013 |
|Venture Round, 1/2014 ||$2.75M|
|Debt, 3/2011 ||$2.25M|
|Debt, 2/2012 ||$2.3M|
BioZone Pharmaceuticals (OTC BB: BZNE) is a public pharmaceutical company that specializes in drug development, manufacturing, and marketing. The company has developed proprietary drug delivery technology that has enabled and revolutionized the administration of drugs that are difficult to formulate. The application of this technology allows the company to pursue reformulation of generic drugs and pursue a low-risk regulatory pathway for NDA approval. Additionally, BioZone provides oral, topical, and injectable drug products for anesthesia, infectious diseases, metabolic diseases, and oncology, and offers a unique line of dermatology products for a variety of dermatological diseases. Flagship products include P&S Liquid and Shampoo and the GlyDerm dermatological care line. The company is currently looking to agressively expand in both size and product line.